Adel R. Rizkala

3 ta ish

Novartis (Switzerland)

1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

   John J.V. McMurray, Milton Packer, Akshay S. Desai +8

   Maqola20146 iqtibos

   ABIABI:AkademIndex/2026.other.295755

2. Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

   Scott D. Solomon, John J.V. McMurray, Inder S. Anand +31

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.295865

3. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

   Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett +22

   Maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.295867